Fidaxomicin for Initial Episode of <i>Clostridioides difficile</i> Infection Reduces Recurrence in Immunocompromised Hosts-a Large Retrospective Cohort Study.

Open Forum Infect Dis · 2025 · PMC12719386 · PMID 41439186

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

In the multivariable analysis, treatment with fidaxomicin demonstrated a trend toward reducing the composite outcome of complications, with an adjusted odds ratio (aOR) of 0.63 (95% CI, .38–1.1; P = .07), although this did not reach statistical significance.

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.

Fidaxomicin for Initial Episode of &lt;i&gt;Clostridioides difficile&lt;/i&gt; Infection Reduces Recurrence in Immunocompromised Hosts-a Large Retrospective Cohort Study.

The sentences

Fidaxomicin for Initial Episode of <i>Clostridioides difficile</i> Infection Reduces Recurrence in Immunocompromised Hosts-a Large Retrospective Cohort Study.